The fourth edition of the World Health Organization (WHO) classification of urogenital
tumours (WHO “blue book”), published in 2016, contains significant revisions. These …

The MiT subfamily of transcription factors includes TFE3, TFEB, TFC, and MiTF. Gene
fusions involving two of these transcription factors have been identified in renal cell …

Abstract The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …

The classification working group of the International Society of Urological Pathology
consensus conference on renal neoplasia was in charge of making recommendations …

Accumulating evidence suggests that renal cell tumors represent a group of histologically
and molecularly heterogeneous diseases, even within the same histological subtype. In …

Context—Histologic diagnosis of renal neoplasm is usually straightforward by routine light
microscopy. However, immunomarkers may be essential in several contexts, including …

Summary The World Health Organization (WHO) 2022 classification of urinary and male
genital tumours (5th edition) has significantly improved our understanding of the …

Xp11 translocation cancers include Xp11 translocation renal cell carcinoma (RCC), Xp11
translocation perivascular epithelioid cell tumor (PEComa), and melanotic Xp11 …

A group of renal tumors composed mainly of cells with clear cytoplasm arranged in papillary
patterns and arising in end-stage kidneys has recently been identified. The aim of our study …

Renal cell carcinoma (RCC) subtypes are increasingly being discerned via their molecular
underpinnings. Frequently this can be correlated to histologic and immunohistochemical …